Come up with a name for your new list and we'll add to it:
Apitope raised a round of funding on January 13, 2014. Investors include
Seventh Framework Programme.
Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves' …